Biological and Pharmaceutical Bulletin p. 491 - 497 (1999)
Update date:2022-08-02
Topics:
Abdel-Hafez, Atef A.
Meselhy, Meselhy R.
Nakamura, Norio
Hattori, Masao
Watanabe, Hiroshi
Murakami, Yukihisa
El-Gendy, Mahmoud A.
Mahfouz, Nadia M.
Mohamed, Tarek A.
Seventeen thiopaeonimetabolin-I adducts were obtained as mixtures of diastereoisomers after incubation of paeoniflorin with Lactobacillus brevis in the presence of various thiols. The anticonvulsant activity of the adducts was investigated in mice using the maximal subcutaneous pentylenetetrazol seizure test and sodium valproate (1.5 mmol/kg) as a positive control. Thirteen adducts showed dose-dependent prolongation of latencies of clonic and tonic convulsions. Maximal protection against convulsions was effectively demonstrated by 8-(nhexylthio)paeonimetabolin I (8) and 8- benzoylthiopaeonimetabolin I (18) at doses of 0.125 and 0.25 mmol/kg, respectively, while 100% protection was only achieved at 0.5 mmol/kg of 8- cyclopentylthiopaeonimetabolin I and 8-(p-tolylthio)paeonimetabolin 1. The principal anticonvulsant activity of the diastereoisomers of 8 and 18 was attributed to their 7S-isomers [ED50 values of 0.09 and 0.12 mmol/kg, and protective indices of 5.0 and 4.0 for 8 (7S) and 18 (7S), respectively], while the 7R counterparts [8 (7R) and 18 (7R)] showed a muscle relaxation effect.
Contact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Shanghai Zhihua ChemTech Co., Ltd.
Contact:+86-13774313779
Address:Room 817 Suite B 3333 Shenjiang Road
Taixing Joxin Bio-tec Co.,Ltd.
website:http://www.joxbio.com
Contact:86-523-87558858 87612088
Address:No.88, chengdong industrial park
Shanghai Yuantai Chemical Products Co., Ltd
Contact:021--66129803
Address:Chengyin Road,Shanghai,China
Shanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Doi:10.1016/j.carres.2012.01.008
(2012)Doi:10.3184/030823409X393682
(2009)Doi:10.1021/jm900528d
(2009)Doi:10.1016/j.ejmech.2009.02.008
(2009)Doi:10.1016/0009-3084(94)02315-8
(1994)Doi:10.1039/c3ra46652c
(2014)
